BMRN vs GAP · P/E 40, rev $2.85B vs P/E 9.9, rev $15.09B
Biomarin Pharmaceutical Inc (BMRN) versus The Gap, Inc. (GAP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Not investment advice. Open the BMRN and GAP stock pages for the full models.
Not investment advice.